Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
05/20/2003 | US6565845 Introducing a viral expression vector having a tumoricidal or susceptibility gene into a mammalian cell and attaching the cell to a support matrix in vitro; transferring the supported cells to mammalian tumor cells; durability; brains |
05/20/2003 | US6565843 Protein-induced tissue morphogenesis |
05/20/2003 | US6565842 Crosslinking gel |
05/20/2003 | US6565831 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
05/20/2003 | CA2102302C Recombinant defective adenoviruses expressing cytokines for an antitumoral treatment |
05/16/2003 | CA2409317A1 Method of enhancing self renewal of stem cells and uses thereof |
05/15/2003 | WO2003040368A2 Pharmaceutical compositions of marine sponge microciona prolifera |
05/15/2003 | WO2003040359A1 Preparing somatic embryo by utilizing rabbit oocyte |
05/15/2003 | WO2003040358A1 Somatic cell derived embryonic stem cells and its differentiated cells |
05/15/2003 | WO2003040355A1 Characterization and isolation of subsets of human embryonic stem cells (hes) and cells associated or derived therefrom |
05/15/2003 | WO2003040351A1 A novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate |
05/15/2003 | WO2003040346A2 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
05/15/2003 | WO2003040319A2 Endothelial cells derived from primate embryonic stem cells |
05/15/2003 | WO2003040316A2 Selective elimination of cd52+ cells and uses thereof |
05/15/2003 | WO2003040298A2 Cell and tissue growth using substances that reversibly bind oxygen |
05/15/2003 | WO2003040170A2 Antibodies to cd40 |
05/15/2003 | WO2003039611A1 Method of forming normal regenerated tissue, the normal regenerated tissue, and method of calibrating senstivity and so on |
05/15/2003 | WO2003039566A2 Methods of treatment in situ in the lungs of mammals |
05/15/2003 | WO2003039565A1 Use of milk serum containing substances with benzodiazepine-like activity as adjuvants to therapy of anxiety and insomnia |
05/15/2003 | WO2003039489A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
05/15/2003 | WO2003039481A2 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof |
05/15/2003 | WO2003039465A2 Treating canker sores with patches to speed healing and relieve pain |
05/15/2003 | WO2003039458A2 TREATMENT OF HUMAN CANCER WITH ADENOVIRAL VECTOR EXPRESSING TNF-α |
05/15/2003 | WO2003039344A2 Methods and compositions for correction of cardiac conduction disturbances |
05/15/2003 | WO2003039311A1 Stem cell and dental pulp harvesting method and apparatus |
05/15/2003 | WO2003039260A2 Probiotic compositions |
05/15/2003 | WO2003016507A3 Generation of multipotent central nervous system stem cells |
05/15/2003 | WO2002083926A3 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
05/15/2003 | WO2001095861A3 Transdifferentiation of glial cells |
05/15/2003 | US20030092738 Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity |
05/15/2003 | US20030092684 Antiinflammatory agents, rheumatic diseases, autoimmune disease; administering tetracyclins |
05/15/2003 | US20030092645 Cloning, expression, viral and delivery vectors and hosts |
05/15/2003 | US20030092177 Preparing preferential cells from mononucler cells in culture; obtain monocytes, incubate with interferon, recover preferental cells |
05/15/2003 | US20030092176 Ependymal neural stem cells and method for their isolation |
05/15/2003 | US20030092174 Tissues or organs for use in xenotransplantation |
05/15/2003 | US20030092163 Probiotic bifidobacterium strains |
05/15/2003 | US20030092145 Viricidal agent for use in the treatment and prevention of viral diseases |
05/15/2003 | US20030092130 DNA encoding polypeptides having interferon-gamma inducing activity |
05/15/2003 | US20030092054 Protein complexes and assays for screening anti-cancer agents |
05/15/2003 | US20030091996 Apoptin-associating protein |
05/15/2003 | US20030091977 Assessment method |
05/15/2003 | US20030091668 Process and composition for controlling fecal hair excretion and trichobezoar formation |
05/15/2003 | US20030091658 Herbal pharmaceutical composition for treatment of HIV/AIDS patients |
05/15/2003 | US20030091651 Oil homogenized with sterols; protective coating for stomach |
05/15/2003 | US20030091650 Ratite oil as a topical adjuvant and transdermal carrier |
05/15/2003 | US20030091596 Antiallergens; enzymeric dissolving of cell wall |
05/15/2003 | US20030091586 Fish immunoglobulin |
05/15/2003 | US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders |
05/15/2003 | US20030091548 Gene therapy for the prevention of autoimmune disease |
05/15/2003 | US20030091547 Antiischemic agents; administering endothelial cells, bone marrow culture |
05/15/2003 | US20030091542 Tissue engineering; wound healing agents; culture product |
05/15/2003 | US20030091541 Method of inducing immunotolerance in an organ transplantation recipient |
05/15/2003 | US20030091540 Uniform spreading into body cavities |
05/15/2003 | US20030091538 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
05/15/2003 | US20030091537 Anticancer agents; gene coding immunomoderator cytokine protein |
05/15/2003 | US20030091535 Mutant virus with defective genome; genetic engineering |
05/15/2003 | CA2505129A1 Pharmaceutical compositions of marine sponge microciona prolifera |
05/15/2003 | CA2466880A1 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
05/15/2003 | CA2466342A1 Characterization and isolation of subsets of human embryonic stem cells (hes) and cells associated or derived therefrom |
05/15/2003 | CA2466203A1 Cross-species somatic cell nuclear transfer using rabbit oocyte |
05/15/2003 | CA2466198A1 Somatic cell derived embryonic stem cells and their differentiated progenies |
05/15/2003 | CA2466128A1 Antibodies to cd40 |
05/15/2003 | CA2466061A1 Oral adhering and dissolving disc made by deposition with licorice extract |
05/15/2003 | CA2466022A1 Probiotic compositions |
05/15/2003 | CA2465950A1 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
05/15/2003 | CA2465908A1 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof |
05/15/2003 | CA2465476A1 Methods and compositions for correction of cardiac conduction disturbances |
05/15/2003 | CA2465361A1 Treatment of human cancer with adenoviral vector expressing tnf-.alpha. |
05/14/2003 | EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby |
05/14/2003 | EP1310260A1 Mixed chimerism and tolerance |
05/14/2003 | EP1309706A2 Modulation of stem cell differentiation |
05/14/2003 | EP1309691A2 Anti-tnf antibodies, compositions, methods and uses |
05/14/2003 | EP1309673A2 Pancreatic progenitor cells |
05/14/2003 | EP1309672A1 Method of producing infectious reovirus |
05/14/2003 | EP1309615A2 Amniotic apoptosis modulating substances |
05/14/2003 | EP1309603A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
05/14/2003 | EP1309361A1 Scaffolds for tissue engineered hair |
05/14/2003 | EP1309337A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage |
05/14/2003 | EP1309334A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
05/14/2003 | EP1309318A1 Consumable container |
05/14/2003 | EP1246631B1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures |
05/14/2003 | EP1140987B1 Peptides for inhibiting hpv e6 proteins |
05/14/2003 | EP1036161A4 Chondrocyte-like cells useful for tissue engineering and methods |
05/14/2003 | EP0814838B1 Antigen presenting system and activation of t-cells |
05/14/2003 | EP0804072B1 Method of cultivating macrophages |
05/14/2003 | EP0751810B1 Method and porous support for removing contaminants |
05/14/2003 | EP0594669B1 Growth factor-responsive neural progenitor cells which can be proliferated in vitro. |
05/14/2003 | CN1418255A Herpes virus strains for gene therapy |
05/14/2003 | CN1418248A Altered strain of modified vaccinia virus ankara (MVA) |
05/14/2003 | CN1418224A TCF responsive element |
05/14/2003 | CN1417333A Cloning, Expression and bioactivity of new actinion toxin |
05/14/2003 | CN1417326A Latent-energy regeneration cell |
05/14/2003 | CN1416891A Pile-treating Chinese medicine |
05/14/2003 | CN1416878A Mastoproliferation treating medicine |
05/14/2003 | CN1416872A Health wine for expelling wind, clearing away cold and removing dampness |
05/14/2003 | CN1416859A Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process |
05/14/2003 | CN1416856A Medicine for treating aplastic anemia |
05/14/2003 | CN1416855A Medicine for treating leukemia |
05/14/2003 | CN1416840A Alopecia treating tincture and its prepn |
05/14/2003 | CN1416838A Health food capsule with functions of sobering up, detoxicating, nourishing heart, tranquilizing and protecting liver and its production process |